These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21608345)

  • 21. New strategies in dopaminergic therapy of Parkinson's disease: the use of a controlled-release formulation. London, England, April 28 and 29, 1989. Proceedings.
    Neurology; 1989 Nov; 39(11 Suppl 2):1-106. PubMed ID: 2586761
    [No Abstract]   [Full Text] [Related]  

  • 22. [Advanced course of Parkinson disease. Little improved motion with continuous intestinal levodopa administration].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2005 Jul; 28(7):245-6. PubMed ID: 16038123
    [No Abstract]   [Full Text] [Related]  

  • 23. Recent advances in the treatment of Parkinson's disease.
    Martocci RJ
    J Am Osteopath Assoc; 1975 Apr; 74(8):730-41. PubMed ID: 1092751
    [No Abstract]   [Full Text] [Related]  

  • 24. A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease.
    Nausieda PA; Pfeiffer RF; Tagliati M; Kastenholz KV; DeRoche C; Slevin JT
    Clin Ther; 2005 Jan; 27(1):58-63. PubMed ID: 15763606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parallel double-blind study of pergolide in Parkinson's disease.
    Jankovic J; Orman J
    Adv Neurol; 1987; 45():551-4. PubMed ID: 3548265
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of Parkinson's disease.
    Lieberman A
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):339-43. PubMed ID: 8507903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nurse's role in clinical trials.
    Amyot D; Gray P; Demong C; Wilson W; Murphy D; Watson J; Duff J
    Can Nurse; 1996 Nov; 92(10):30-2. PubMed ID: 9095759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New concepts in the treatment of Parkinson's disease.
    Ahlskog JE; Wilkinson JM
    Am Fam Physician; 1990 Feb; 41(2):574-84. PubMed ID: 1967895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An integrated approach to patient management in Parkinson's disease.
    Lieberman A
    Neurol Clin; 1992 May; 10(2):553-65. PubMed ID: 1350053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbidopa/levodopa pharmacy errors in Parkinson's disease.
    Khadem NR; Nirenberg MJ
    Mov Disord; 2010 Dec; 25(16):2867-71. PubMed ID: 20818662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment challenges in early stage Parkinson's disease.
    Tetrud J
    Neurol Clin; 2004 Oct; 22(3 Suppl):S19-33. PubMed ID: 15501364
    [No Abstract]   [Full Text] [Related]  

  • 32. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
    Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New drugs for Parkinson's disease.
    Med Lett Drugs Ther; 1976 Dec; 18(27):117-8. PubMed ID: 1004371
    [No Abstract]   [Full Text] [Related]  

  • 34. An update on the diagnosis and treatment of Parkinson disease.
    Rizek P; Kumar N; Jog MS
    CMAJ; 2016 Nov; 188(16):1157-1165. PubMed ID: 27221269
    [No Abstract]   [Full Text] [Related]  

  • 35. After the diagnosis: living with Parkinson's. There's no cure for Parkinson's disease, but new treatments can ease the symptoms and prolong independence.
    Harv Womens Health Watch; 2006 Jun; 13(10):2-4. PubMed ID: 16841381
    [No Abstract]   [Full Text] [Related]  

  • 36. Case report: successful use of rectally administered levodopa-carbidopa.
    Cooper SD; Ismail HA; Frank C
    Can Fam Physician; 2001 Jan; 47():112-3. PubMed ID: 11212422
    [No Abstract]   [Full Text] [Related]  

  • 37. Motor fluctuations in Parkinson's disease.
    Weiner WJ
    Rev Neurol Dis; 2006; 3(3):101-8. PubMed ID: 17047575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of deprenyl and levodopa on the progression of Parkinson's disease.
    Olanow CW; Hauser RA; Gauger L; Malapira T; Koller W; Hubble J; Bushenbark K; Lilienfeld D; Esterlitz J
    Ann Neurol; 1995 Nov; 38(5):771-7. PubMed ID: 7486869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale for continuous dopaminomimetic therapy of Parkinson's disease.
    Chase TN; Baronti F; Fabbrini G; Heuser IJ; Juncos JL; Mouradian MM
    Neurology; 1989 Nov; 39(11 Suppl 2):7-10; discussion 19. PubMed ID: 2685653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A young onset Parkinson's patient: a case study.
    Jung SK
    J Neurosci Nurs; 2004 Oct; 36(5):273-7. PubMed ID: 15524245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.